Research Update

RNS Number:4961R
BTG PLC
30 October 2003


30 October 2003


BTG plc: Analyst briefing

BTG plc (LSE: BGC), the global technology commercialisation company, announces
that it is holding a briefing for analysts at 3.30pm today.  The briefing will
consist of a number of presentations on Varisolve(R), the novel varicose veins
treatment being developed by Provensis, BTG's subsidiary.  The presentations
will summarise the current status of development, including: a clinician's
perspective, the preliminary results of the European pivotal Phase III trial,
the overall regulatory status, manufacturing, the market opportunity and
commercialisation options.

The presentations will be broadcast via BTG's website (www.btgplc.com) from
3.30pm, and available as an archive thereafter for three months.

                                      Ends


For further information contact:

BTG                                                     Financial Dynamics
Andy Burrows, Director of Investor Relations            Ben Atwell
[phone]                                     [phone]


About BTG

BTG finds, develops and commercialises emerging technologies in the life and
physical sciences. These innovations are protected by a strong portfolio of
intellectual property that BTG develops and enhances. BTG then captures the
value in these technologies through licensing and venturing activities. From the
origins of its business in 1949, BTG has commercialised major innovations such
as Magnetic Resonance Imaging (MRI), recombinant factor IX blood-clotting
protein, Campath(R) (alemtuzumab) and Multilevel Cell (MLC) memory. BTG is
quoted on the London Stock Exchange under the symbol "BGC" and operates from
offices in London and Philadelphia, with representation in Tokyo. BTG operates
through wholly owned subsidiaries, BTG International Ltd. and BTG International
Inc. in the UK and USA, respectively. Further information on BTG can be found at
www.btgplc.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RESNKKKBQBDDKKN